Dr Tayot is the founder of privately owned company Khorionyx.
He graduated from the Institut National des Sciences Appliquées (INSA) in Lyon, France. He obtained his PhD in Biochemistry from Université Claude Bernard in Lyon, France.
Since 1967, Dr Tayot spent twenty years in the R&D division of Institut Mérieux (now: Sanofi Pasteur). He played a leading role in the development and scale-up of purification and production technologies in vaccines, blood and placental products.
From 1987 to 1998, he was the General Manager of Imedex (a subsidiary of Institut Mérieux), where his team of 50 people developed the industrial processes and medical applications of animal and placental human collagens. These achievements became the basis of 12 patent families and four companies:
He also collaborated with the Genzyme founders, to extract the placental glucocerebrosidase at the origin of Ceredase® for the therapy of the Gaucher’s disease.
- Episkin, a subsidiary of L’Oreal, producing human skin models for testing cosmetics;
- Symatèse, a subsidiary of Laboratoires Pérouse specialised in biopolymers;
- Imedex Biomatériaux, a division of Sofradim, now a Covidien company;
- Albiorex, a Florida based start-up focused on human placental collagens development.
From 1998 to 2005, he was the general manager of Imedex Biomatériaux.